Trial Evaluating Safety, Tolerability and Immune Response of AG-707

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 31, 2006

Conditions
Genital Herpes
Interventions
DRUG

AG-707

Trial Locations (3)

Unknown

Indianapolis

Portland

Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Agenus Inc.

INDUSTRY